文献速递妇科

MEMORY研究:早期宫颈癌微创与开腹根治性子宫切除术的多中心生存结局比较

The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes.
PubMed 文献 · Gynecol Oncol · 2022-07-22

多中心回顾性队列研究纳入2009 FIGO IA1(伴淋巴血管间隙浸润)至IB1期宫颈癌1093例,比较微创(715例,其中机器人558例)与开腹(378例)根治性子宫切除术的生存结局。微创组与开腹组3年无进展生存率分别为87.9%与89%(P=0.6),3年总生存率分别为95.8%与96.6%(P=0.8),多因素分析复发/死亡调整HR为0.70(95%CI 0.47-1.03;P=0.07),死亡调整HR为0.81(95%CI 0.43-1.52;P=0.5)。

要点

  • 微创与开腹根治性子宫切除术3年无进展生存率分别为87.9%与89%(P=0.6)。
  • 微创与开腹组3年总生存率分别为95.8%与96.6%(P=0.8)。
  • 多因素分析复发/死亡调整HR为0.70(95%CI 0.47-1.03;P=0.07),未达统计学显著。

核心结论

  • 多中心分析显示,早期宫颈癌微创根治性子宫切除术与开腹手术相比未显示损害肿瘤学结局,无进展生存与总生存相似。

研究设计与样本

  • 多中心回顾性队列研究,纳入2009 FIGO IA1期(伴淋巴血管间隙浸润)至IB1期宫颈癌患者,时间范围2007年1月至2016年12月,排除术前治疗者,纳入鳞癌、腺癌及腺鳞癌,共1093例,其中微创715例(机器人558例,78%)、开腹378例。

主要发现

  • 开腹队列中肿瘤>2 cm、子宫切除标本残留病灶及接受辅助治疗的患者更多。
  • 微创与开腹队列中位随访分别为38.5个月(范围0.03-149.51)与54.98个月(范围0.03-145.20)。
  • 3年无进展生存率微创组87.9%(95%CI 84.9-90.4%)vs 开腹组89%(95%CI 84.9-92%)(P=0.6)。
  • 多因素分析复发/死亡调整HR为0.70(95%CI 0.47-1.03;P=0.07)。
  • 3年总生存率微创组95.8%(95%CI 93.6-97.2%)vs 开腹组96.6%(95%CI 93.8-98.2%)(P=0.8);多因素分析死亡调整HR为0.81(95%CI 0.43-1.52;P=0.5)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Laparoscopic Approach to Cervical Cancer (LACC) trial found that minimally invasive radical hysterectomy compared to open radical hysterectomy compromised oncologic outcomes and was associated with worse progression-free survival (PFS) and overall survival (OS) in early-stage cervical carcinoma. We sought to assess oncologic outcomes at multiple centers between minimally invasive (MIS) radical hysterectomy and OPEN radical hysterectomy. METHODS: This is a multi-institutional, retrospective cohort study of patients with 2009 FIGO stage IA1 (with lymphovascular space invasion) to IB1 cervical carcinoma from 1/2007-12/2016. Patients who underwent preoperative therapy were excluded. Squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinomas were included. Appropriate statistical tests were used. RESULTS: We identified 1093 cases for analysis-715 MIS (558 robotic [78%]) and 378. OPEN procedures. The OPEN cohort had more patients with tumors >2 cm, residual disease in the hysterectomy specimen, and more likely to have had adjuvant therapy. Median follow-up for the MIS and OPEN cohorts were 38.5 months (range, 0.03-149.51) and 54.98 months (range, 0.03-145.20), respectively. Three-year PFS rates were 87.9% (95% CI: 84.9-90.4%) and 89% (95% CI: 84.9-92%), respectively (P = 0.6). On multivariate analysis, the adjusted HR for recurrence/death was 0.70 (95% CI: 0.47-1.03; P = 0.07). Three-year OS rates were 95.8% (95% CI: 93.6-97.2%) and 96.6% (95% CI: 93.8-98.2%), respectively (P = 0.8). On multivariate analysis, the adjusted HR for death was 0.81 (95% CI: 0.43-1.52; P = 0.5). CONCLUSION: This multi-institutional analysis showed that an MIS compared to OPEN radical hysterectomy for cervical cancer did not appear to compromise oncologic outcomes, with similar PFS and OS.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Leitao MM, Zhou QC, Brandt B, et al. The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes. Gynecol Oncol. 2022. PMID: 35879128. doi:10.1016/j.ygyno.2022.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。